Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-Encoded CTL peptide epitope

K. Wasserman, M. M. Corsi, L. Szekely, K. Kono, H. H. Maes, R. Kiessling

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tumour-derived peptides have been surveyed, in a variety of systems, for their ability to elicit cytokine release from class I restricted T cells. Analogous studies on ovarian carcinoma have employed the antigen-processing defective T2 cell line. Purified dendritic cells (DC) have been reported to act as highly effective APC. A facile method was developed whereby DC-like cells were generated from monocyte precursors. Herein, evidence is presented suggesting DC-like cells are superior to T2 with respect to their ability to present a defined CTL epitope associated with ovarian carcinoma.

Original languageEnglish
Pages (from-to)678-682
Number of pages5
JournalScandinavian Journal of Immunology
Volume45
Issue number6
Publication statusPublished - 1997

Fingerprint

Dendritic Cells
Epitopes
Monocytes
Peptides
Carcinoma
Antigen Presentation
Cytokines
T-Lymphocytes
Cell Line
In Vitro Techniques
Neoplasms

ASJC Scopus subject areas

  • Immunology

Cite this

Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-Encoded CTL peptide epitope. / Wasserman, K.; Corsi, M. M.; Szekely, L.; Kono, K.; Maes, H. H.; Kiessling, R.

In: Scandinavian Journal of Immunology, Vol. 45, No. 6, 1997, p. 678-682.

Research output: Contribution to journalArticle

Wasserman, K. ; Corsi, M. M. ; Szekely, L. ; Kono, K. ; Maes, H. H. ; Kiessling, R. / Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-Encoded CTL peptide epitope. In: Scandinavian Journal of Immunology. 1997 ; Vol. 45, No. 6. pp. 678-682.
@article{3cb002f43c8c4b91b4ba9c9c2dabb833,
title = "Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-Encoded CTL peptide epitope",
abstract = "Tumour-derived peptides have been surveyed, in a variety of systems, for their ability to elicit cytokine release from class I restricted T cells. Analogous studies on ovarian carcinoma have employed the antigen-processing defective T2 cell line. Purified dendritic cells (DC) have been reported to act as highly effective APC. A facile method was developed whereby DC-like cells were generated from monocyte precursors. Herein, evidence is presented suggesting DC-like cells are superior to T2 with respect to their ability to present a defined CTL epitope associated with ovarian carcinoma.",
author = "K. Wasserman and Corsi, {M. M.} and L. Szekely and K. Kono and Maes, {H. H.} and R. Kiessling",
year = "1997",
language = "English",
volume = "45",
pages = "678--682",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-Encoded CTL peptide epitope

AU - Wasserman, K.

AU - Corsi, M. M.

AU - Szekely, L.

AU - Kono, K.

AU - Maes, H. H.

AU - Kiessling, R.

PY - 1997

Y1 - 1997

N2 - Tumour-derived peptides have been surveyed, in a variety of systems, for their ability to elicit cytokine release from class I restricted T cells. Analogous studies on ovarian carcinoma have employed the antigen-processing defective T2 cell line. Purified dendritic cells (DC) have been reported to act as highly effective APC. A facile method was developed whereby DC-like cells were generated from monocyte precursors. Herein, evidence is presented suggesting DC-like cells are superior to T2 with respect to their ability to present a defined CTL epitope associated with ovarian carcinoma.

AB - Tumour-derived peptides have been surveyed, in a variety of systems, for their ability to elicit cytokine release from class I restricted T cells. Analogous studies on ovarian carcinoma have employed the antigen-processing defective T2 cell line. Purified dendritic cells (DC) have been reported to act as highly effective APC. A facile method was developed whereby DC-like cells were generated from monocyte precursors. Herein, evidence is presented suggesting DC-like cells are superior to T2 with respect to their ability to present a defined CTL epitope associated with ovarian carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0030923699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030923699&partnerID=8YFLogxK

M3 - Article

C2 - 9201308

AN - SCOPUS:0030923699

VL - 45

SP - 678

EP - 682

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 6

ER -